IC
VTYX

Ikarian Capital’s Ventyx Biosciences VTYX Stock Holding History

Ikarian Capital’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-958,704
Closed -$8.66M – 211
2025
Q4 		$8.66M Sell
958,704
-350,900
-27% -$2.62M 0.68% 42
2025
Q3 		$4.07M Buy
1,309,604
+342,014
+35% +$906K 0.41% 65
2025
Q2 		$2.07M Sell
967,590
-250,000
-21% -$404K 0.4% 67
2025
Q1 		$1.4M Buy
1,217,590
+125,000
+11% +$215K 0.17% 83
2024
Q4 		$2.39M Buy
1,092,590
+899,943
+467% +$2.04M 0.33% 74
2024
Q3 		$420K Sell
192,647
-250,000
-56% -$575K 0.06% 119
2024
Q2 		$1.02M Sell
442,647
-65,000
-13% -$270K 0.18% 77
2024
Q1 		$2.79M Buy
507,647
+501,733
+8,484% +$2.29M 0.31% 76
2023
Q4 		$14.6K Buy
+5,914
New +$56.2K ﹤0.01% 133
2023
Q2 		– Sell
-65,000
Closed -$2.24M – 157
2023
Q1 		$2.18M Buy
+65,000
New +$2.53M 0.49% 55

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ikarian Capital's VTYX Position: Q1 2026 in Review

Ikarian Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 958,704 shares — an estimated $8.66M sold.

Ikarian Capital first reported a position in VTYX in Q1 2023 and held it in 10 quarters. The position peaked at $8.66M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Ikarian Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Ikarian Capital sold 958,704 Ventyx Biosciences shares in Q1 2026, an estimated $8.66M.
  • Ikarian Capital first reported a position in Ventyx Biosciences in Q1 2023 and held it in 10 quarters.
  • Ikarian Capital's Ventyx Biosciences position peaked at $8.66M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.